A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity-Reference-Cited by-同舟云学术

A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity

Published:2010-04-13 Issue:10 Volume:25 Page:1409-1417
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Poorkaj Parvoneh,Raskind Wendy H.,Leverenz James B.,Matsushita Mark,Zabetian Cyrus P.,Samii Ali,Kim Sophia,Gazi Nayiry,Nutt John G.,Wolff John,Yearout Dora,Greenup J. Lynne,Steinbart Ellen J.,Bird Thomas D.

Funder

Department of Veterans Affairs

University of Washington Royalty Research Fund

Mary Gates Research Scholarship

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference35 articles.

1. Molecular basis of Parkinson's disease;Yang;Neuroreport,2009

2. A susceptibility locus for Parkinson's disease maps to chromosome 2p13;Gasser;Nat Genet,1998

3. Age at onset in two common neurodegenerative diseases is genetically controlled;Li;Am J Hum Genet,2002

4. Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families;Pankratz;Hum Mol Genet,2003

5. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease;Xu;Neurology,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. V-ATPase Dysfunction in the Brain: Genetic Insights and Therapeutic Opportunities;Cells;2024-08-28

2. Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies;Journal of Neurology;2024-03-30

3. Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases;Translational Neurodegeneration;2023-06-08

4. Pediatric-Onset Epilepsy and Developmental Epileptic Encephalopathies Followed by Early-Onset Parkinsonism;International Journal of Molecular Sciences;2023-02-14

5. Reduced gene dosage is a common mechanism of neuropathologies caused by ATP6AP2 splicing mutations;Parkinsonism & Related Disorders;2022-08